SEC Filing Summary

This filing is an amendment to a previous Schedule 13D filing concerning Pacira BioSciences, Inc. The amendment details the nomination of three directors by DOMA Perpetual Capital Management LLC and its affiliates. These nominees are Christopher Dennis, Oliver Benton Curtis III, and Eric de Armas. The filing expresses dissatisfaction with the current management and board performance, citing stock price decline, increased expenses, and executive compensation. DOMA Perpetual Capital Management LLC, along with its affiliates, beneficially owns approximately 7.3% of Pacira BioSciences, Inc. common stock. The filing also includes a press release from DOMA announcing the nominations and outlining their concerns and proposals for the company, including a potential sale process.